Noncanonical functions of Ku may underlie essentiality in human cells.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
27 07 2023
Historique:
received: 17 02 2023
accepted: 20 07 2023
medline: 31 7 2023
pubmed: 28 7 2023
entrez: 27 7 2023
Statut: epublish

Résumé

The Ku70/80 heterodimer is a key player in non-homologous end-joining DNA repair but is involved in other cellular functions like telomere regulation and maintenance, in which Ku's role is not fully characterized. It was previously reported that knockout of Ku80 in a human cell line results in lethality, but the underlying cause of Ku essentiality in human cells has yet to be fully explored. Here, we established conditional Ku70 knockout cells using CRISPR/Cas9 editing to study the essentiality of Ku70 function. While we observed loss of cell viability upon Ku depletion, we did not detect significant changes in telomere length, nor did we record lethal levels of DNA damage upon loss of Ku. Analysis of global proteome changes following Ku70 depletion revealed dysregulations of several cellular pathways including cell cycle/mitosis, RNA related processes, and translation/ribosome biogenesis. Our study suggests that the driving cause of loss of cell viability in Ku70 knockouts is not linked to the functions of Ku in DNA repair or at telomeres. Moreover, our data shows that loss of Ku affects multiple cellular processes and pathways and suggests that Ku plays critical roles in cellular processes beyond DNA repair and telomere maintenance to maintain cell viability.

Identifiants

pubmed: 37500706
doi: 10.1038/s41598-023-39166-7
pii: 10.1038/s41598-023-39166-7
pmc: PMC10374653
doi:

Substances chimiques

DNA-Binding Proteins 0
Antigens, Nuclear 0
Ku Autoantigen EC 4.2.99.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12162

Informations de copyright

© 2023. The Author(s).

Références

Lieber, M. R. The mechanism of DSB repair by the NHEJ. Annu. Rev. Biochem. 79, 181–211 (2010).
pubmed: 20192759 pmcid: 3079308
Chang, H. H. Y., Pannunzio, N. R., Adachi, N. & Lieber, M. R. Non-homologous DNA end joining and alternative pathways to double-strand break repair. Nat. Rev. Mol. Cell Biol. 18, 495–506 (2017).
pubmed: 28512351 pmcid: 7062608
Mari, P. O. et al. Dynamic assembly of end-joining complexes requires interaction between Ku70/80 and XRCC4. Proc. Natl. Acad. Sci. U.S.A. 103, 18597–18602 (2006).
pubmed: 17124166 pmcid: 1693708
Zahid, S. et al. The multifaceted roles of Ku70/80. Int. J. Mol. Sci. 22, 4134 (2021).
pubmed: 33923616 pmcid: 8073936
Fell, V. L. & Schild-Poulter, C. The Ku heterodimer: Function in DNA repair and beyond. Mutat. Res. Rev. Mutat. Res. 763, 15–29 (2015).
pubmed: 25795113
Hsu, H. L., Yannone, S. M. & Chen, D. J. Defining interactions between DNA-PK and ligase IV/XRCC4. DNA Repair (Amst). 1, 225–235 (2002).
pubmed: 12509254
Frit, P., Ropars, V., Modesti, M., Charbonnier, J. B. & Calsou, P. Plugged into the Ku-DNA hub: The NHEJ network. Prog. Biophys. Mol. Biol. 147, 62–76 (2019).
pubmed: 30851288
Abbasi, S., Parmar, G., Kelly, R. D., Balasuriya, N. & Schild-Poulter, C. The Ku complex: Recent advances and emerging roles outside of non-homologous end-joining. Cell. Mol. Life Sci.78, 4589–4613 (2021).
pubmed: 33855626
Christie, S. M., Fijen, C. & Rothenberg, E. V(D)J Recombination: Recent insights in formation of the recombinase complex and recruitment of DNA repair machinery. Front. Cell Dev. Biol. 10, 886718 (2022).
pubmed: 35573672 pmcid: 9099191
Indiviglio, S. M. & Bertuch, A. A. Ku’s essential role in keeping telomeres intact. Proc. Natl. Acad. Sci. U.S.A. 106, 12217–12218 (2009).
pubmed: 19622731 pmcid: 2718394
De Lange, T. Shelterin-mediated telomere protection. Annu. Rev. Genet. 52, 223–247 (2018).
pubmed: 30208292
Shay, J. W. & Wright, W. E. Telomeres and telomerase: Three decades of progress. Nat. Rev. Genet. 20, 299–309 (2019).
pubmed: 30760854
Fisher, T. S. & Zakian, V. A. Ku: A multifunctional protein involved in telomere maintenance. DNA Repair 4, 1215–1226 (2005).
pubmed: 15979949
Porter, S. E., Greenwell, P. W., Ritchie, K. B. & Petes, T. D. The DNA-binding protein Hdf1p (a putative Ku homologue) is required for maintaining normal telomere length in Saccharomyces cerevisiae. Nucleic Acids Res. 24, 582–585 (1996).
pubmed: 8604297 pmcid: 145698
Melnikova, L., Biessmann, H. & Georgiev, P. The Ku protein complex is involved in length regulation of Drosophila telomeres. Genetics 170, 221–235 (2005).
pubmed: 15781709 pmcid: 1449706
Hsu, H. L. et al. Ku acts in a unique way at the mammalian telomere to prevent end joining. Genes Dev. 14, 2807–2812 (2000).
pubmed: 11090128 pmcid: 317061
Samper, E., Goytisolo, F. A., Slijepcevic, P., Van Buul, P. P. W. & Blasco, M. A. Mammalian Ku86 protein prevents telomeric fusions independently of the length of TTAGGG repeats and the G-strand overhang. EMBO Rep. 1, 244–252 (2000).
pubmed: 11256607 pmcid: 1083725
D’Adda di Fagagna, F. et al. Effects of DNA nonhomologous end-joining factors on telomere length and chromosomal stability in mammalian cells. Curr. Biol. 11, 1192–1196 (2001).
pubmed: 11516951
Sui, J., Zhang, S. & Chen, B. P. C. DNA-dependent protein kinase in telomere maintenance and protection. Cell. Mol. Biol. Lett. 25, 2 (2020).
pubmed: 31988640 pmcid: 6969447
Chai, W., Ford, L. P., Lenertz, L., Wright, W. E. & Shay, J. W. Human Ku70/80 associates physically with telomerase through interaction with hTERT. J. Biol. Chem. 277, 47242–47247 (2002).
pubmed: 12377759
Li, G., Nelsen, C. & Hendrickson, E. A. Ku86 is essential in human somatic cells. Proc. Natl. Acad. Sci. U.S.A. 99, 832–837 (2002).
pubmed: 11792868 pmcid: 117391
Wang, Y., Ghosh, G. & Hendrickson, E. A. Ku86 represses lethal telomere deletion events in human somatic cells. Proc. Natl. Acad. Sci. U.S.A. 106, 12430–12435 (2009).
pubmed: 19581589 pmcid: 2718384
Mazzucco, G. et al. Telomere damage induces internal loops that generate telomeric circles. Nat. Commun. 11, 5297 (2020).
pubmed: 33082350 pmcid: 7576219
Nussenzweig, A. et al. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature 382, 551–555 (1996).
pubmed: 8700231
Gu, Y. et al. Growth retardation and leaky SCID phenotype of Ku70-deficient mice. Immunity 7, 653–665 (1997).
pubmed: 9390689
Li, H., Vogel, H., Holcomb, V. B., Gu, Y. & Hasty, P. Deletion of Ku70, Ku80, or both causes early aging without substantially increased cancer. Mol. Cell. Biol. 27, 8205–8214 (2007).
pubmed: 17875923 pmcid: 2169178
De Sena-Tomas, C. et al. Fungal Ku prevents permanent cell cycle arrest by suppressing DNA damage signaling at telomeres. Nucleic Acids Res. 43, 2138–2151 (2015).
pubmed: 25653166 pmcid: 4344518
Blomen, V. A. et al. Gene essentiality and synthetic lethality in haploid human cell. Science 350, 1092–1096 (2015).
pubmed: 26472760
Hart, T. et al. High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities. Cell 163, 1515–1526 (2015).
pubmed: 26627737
Wang, T. et al. Identification and characterization of essential genes in the human genome. Science 350, 1096–1101 (2015).
pubmed: 26472758 pmcid: 4662922
Ghosh, G., Li, G., Myung, K. & Hendrickson, E. A. The lethality of Ku86 (XRCC5) loss-of-function mutations in human cells is independent of p53 (TP53). Radiat. Res. 167, 66–79 (2007).
pubmed: 17214517
Uegaki, K., Adachi, N., So, S., Iiizumi, S. & Koyama, H. Heterozygous inactivation of human Ku70/Ku86 heterodimer does not affect cell growth, double-strand break repair, or genome integrity. DNA Repair (Amst). 5, 303–311 (2006).
pubmed: 16325483
Fattah, K. R., Ruis, B. L. & Hendrickson, E. A. Mutations to Ku reveal differences in human somatic cell lines. DNA Repair (Amst). 7, 762–774 (2008).
pubmed: 18387344 pmcid: 2427147
Wolfs, J. M. et al. Biasing genome-editing events toward precise length deletions with an RNA-guided TevCas9 dual nuclease. Proc. Natl. Acad. Sci. U.S.A. 113, 14988–14993 (2016).
pubmed: 27956611 pmcid: 5206545
Mashal, R. D., Koontz, J. & Sklar, J. Detection of mutations by cleavage of DNA heteroduplexes with bacteriophage resolvases. Nat. Genet. 9, 177–183 (1995).
pubmed: 7719346
Myung, K. et al. Regulation of Telomere length and suppression of genomic instability in human somatic cells by Ku86. Mol. Cell. Biol. 24, 5050–5059 (2004).
pubmed: 15143195 pmcid: 416406
Jaco, I., Muñoz, P. & Blasco, M. A. Role of human Ku86 in telomere length maintenance and telomere capping. Cancer Res. 64, 7271–7278 (2004).
pubmed: 15492246
Pansare, K. et al. Raman spectroscopy: An exploratory study to identify post-radiation cell survival. Appl. Spectrosc. 74(5), 553–562 (2020).
pubmed: 32031014
Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).
pubmed: 30944313 pmcid: 6447622
Slattery, S. S. et al. Plasmid-based complementation of large deletions in Phaeodactylum tricornutum biosynthetic genes generated by Cas9 editing. Sci. Rep. 10, 13879 (2020).
pubmed: 32807825 pmcid: 7431573
Rossiello, F., Jurk, D., Passos, J. F. & D’Adda di Fagagna, F. Telomere dysfunction in ageing and age-related diseases. Nat. Cell Biol. 24(2), 135–147 (2022).
pubmed: 35165420 pmcid: 8985209
Li, B., Reddy, S. & Comai, L. Depletion of Ku70/80 reduces the levels of extrachromosomal telomeric circles and inhibits proliferation of ALT cells. Aging (Albany NY) 3, 395–406 (2011).
pubmed: 21512205
He, B., Lu, N. & Zhou, Z. Cellular and nuclear degradation during apoptosis. Curr. Opin. Cell Biol. 21, 900–912 (2009).
pubmed: 19781927 pmcid: 2787732
Xu, X. et al. The novel presenilin-1-associated protein is a proapoptotic mitochondrial protein. J. Biol. Chem. 277, 48913–48922 (2002).
pubmed: 12377771
Lamarca, V. et al. Two isoforms of PSAP/MTCH1 share two proapoptotic domains and multiple internal signals for import into the mitochondrial outer membrane. Am. J. Physiol. Cell Physiol. 293, C1347–C1361 (2007).
pubmed: 17670888
Bensaad, K. et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126, 107–120 (2006).
pubmed: 16839880
Lee, P., Vousden, K. H. & Cheung, E. C. TIGAR, TIGAR, burning bright. Cancer Metab. 2, 1 (2014).
pubmed: 24383451 pmcid: 3892023
Widden, H. & Placzek, W. J. The multiple mechanisms of MCL1 in the regulation of cell fate. Commun. Biol. 4, 1029 (2021).
pubmed: 34475520 pmcid: 8413315
Lim, J. W., Kim, H. & Kim, K. H. Expression of Ku70 and Ku80 mediated by NF-κB and cyclooxygenase-2 is related to proliferation of human gastric cancer cells. J. Biol. Chem. 277, 46093–46100 (2002).
pubmed: 12324457
Liu, T., Zhang, L., Joo, D. & Sun, S. C. NF-κB signaling in inflammation. Signal Transduct. Target. Ther. 2, 17023 (2017).
pubmed: 29158945 pmcid: 5661633
Piñeiro, D. et al. Identification of the RNA polymerase I-RNA interactome. Nucleic Acids Res. 46, 11002–11013 (2018).
pubmed: 30169671 pmcid: 6237751
Shao, Z. et al. DNA-PKcs has KU-dependent function in rRNA processing and haematopoiesis. Nature 579, 291–296 (2020).
pubmed: 32103174
Muñoz, P., Zdzienicka, M. Z., Blanchard, J.-M. & Piette, J. Hypersensitivity of Ku-deficient cells toward the DNATopoisomerase II Inhibitor ICRF-193 suggests a novel role for KuAntigen during the G2 and M phases of the cell cycle. Mol. Cell. Biol. 18, 5797–5808 (1998).
pubmed: 9742097 pmcid: 109166
Rampakakis, E., Di Paola, D. & Zannis-Hadjopoulos, M. Ku is involved in cell growth, DNA replication and G1-S transition. J. Cell Sci. 121, 590–600 (2008).
pubmed: 18252799
You, W. et al. Downregulation of myosin VI reduced cell growth and increased apoptosis in human colorectal cancer. Acta Biochim. Biophys. Sin. (Shanghai) 48, 430–436 (2016).
pubmed: 27044563
Wang, D. et al. MYO6 knockdown inhibits the growth and induces the apoptosis of prostate cancer cells by decreasing the phosphorylation of ERK1/2 and PRAS40. Oncol. Rep. 36, 1285–1292 (2016).
pubmed: 27431378
O’Loughlin, T., Masters, T. A. & Buss, F. The MYO6 interactome reveals adaptor complexes coordinating early endosome and cytoskeletal dynamics. EMBO Rep. 19, e44884 (2018).
pubmed: 29467281 pmcid: 5891429
Eto, K., Goto, S., Nakashima, W., Ura, Y. & Abe, S. I. Loss of programmed cell death 4 induces apoptosis by promoting the translation of procaspase-3 mRNA. Cell Death Differ. 19, 573–581 (2012).
pubmed: 21959934
Matsuhashi, S., Manirujjaman, M., Hamajima, H. & Ozaki, I. Molecular sciences control mechanisms of the tumor suppressor PDCD4: Expression and functions. Int. J. Mol. Sci. 20, 2304 (2019).
doi: 10.3390/ijms20092304 pubmed: 31075975 pmcid: 6539695
Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281–2308 (2013).
pubmed: 24157548 pmcid: 3969860
Strathdee, C. A., McLeod, M. R. & Hall, J. R. Efficient control of tetracycline-responsive gene expression from an autoregulated bi-directional expression vector. Gene 229, 21–29 (1999).
pubmed: 10095100
Engler, C., Kandzia, R. & Marillonnet, S. A one pot, one step, precision cloning method with high throughput capability. PLoS ONE 3, e3647 (2008).
pubmed: 18985154 pmcid: 2574415
Maitland, M. E. R., Kuljanin, M., Wang, X., Lajoie, G. A. & Schild-Poulter, C. Proteomic analysis of ubiquitination substrates reveals a CTLH E3 ligase complex-dependent regulation of glycolysis. FASEB J. 35, e21825 (2021).
pubmed: 34383978
Perez-Riverol, Y. et al. The PRIDE database and related tools and resources in 2019: Improving support for quantification data. Nucleic Acids Res. 47, D442–D450 (2019).
pubmed: 30395289

Auteurs

Rachel D Kelly (RD)

Department of Biochemistry, Western University, London, ON, Canada.
Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.

Gursimran Parmar (G)

Department of Biochemistry, Western University, London, ON, Canada.
Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.

Laila Bayat (L)

Department of Biochemistry, Western University, London, ON, Canada.
Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.

Matthew E R Maitland (MER)

Department of Biochemistry, Western University, London, ON, Canada.
Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.

Gilles A Lajoie (GA)

Department of Biochemistry, Western University, London, ON, Canada.

David R Edgell (DR)

Department of Biochemistry, Western University, London, ON, Canada.

Caroline Schild-Poulter (C)

Department of Biochemistry, Western University, London, ON, Canada. cschild-poulter@robarts.ca.
Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada. cschild-poulter@robarts.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH